Intra-arterial infusion chemotherapy versus isolated upper abdominal perfusion for advanced pancreatic cancer: a retrospective cohort study on 454 patients

[1] Aigner KR(2005)Celiac axis infusion and microembolization for advanced stage III/IV pancreatic cancer—a phase II study on 265 cases Anticancer Res 25 4407-4412

[2] Gailhofer S(1998)Regional versus systemic chemotherapy for advanced pancreatic cancer: a randomized study Hepatogastroenterology 45 1125-1129

[3] Aigner KR(2018)Carotid artery infusion via implantable catheters for squamous cell carcinoma of the tonsils World J Surg Oncol 16 104-268

[4] Gailhofer S(2019)Short-term intra-arterial infusion chemotherapy for head and neck cancer patients maintaining quality of life J Cancer Res Clin Oncol 145 261-306

[5] Kopp S(2011)5-Fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma Oncology 80 301-589

[6] Aigner KR(2019)The significance of ascites in patients with pancreatic ductal adenocarcinoma: a case-control study Pancreas 48 585-949

[7] Gailhofer S(1999)Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis World J Surg 23 946-57

[8] Aigner K(2003)randomised trial of gemcitabine versus Flec regimen given intra-arterially for patients with unresectable pancreatic cancer J Exp Clin Cancer Res 22 51-v68

[9] Aigner KR(2015)Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 26 v56-e28

[10] Selak E(2017)Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysis Clin Res Hepatol Gastroenterol 41 e26-2925

[1] Aigner KR(2005)Celiac axis infusion and microembolization for advanced stage III/IV pancreatic cancer—a phase II study on 265 cases Anticancer Res 25 4407-4412

[2] Gailhofer S(1998)Regional versus systemic chemotherapy for advanced pancreatic cancer: a randomized study Hepatogastroenterology 45 1125-1129

[3] Aigner KR(2018)Carotid artery infusion via implantable catheters for squamous cell carcinoma of the tonsils World J Surg Oncol 16 104-268

[4] Gailhofer S(2019)Short-term intra-arterial infusion chemotherapy for head and neck cancer patients maintaining quality of life J Cancer Res Clin Oncol 145 261-306

[5] Kopp S(2011)5-Fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma Oncology 80 301-589

[6] Aigner KR(2019)The significance of ascites in patients with pancreatic ductal adenocarcinoma: a case-control study Pancreas 48 585-949

[7] Gailhofer S(1999)Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis World J Surg 23 946-57

[8] Aigner K(2003)randomised trial of gemcitabine versus Flec regimen given intra-arterially for patients with unresectable pancreatic cancer J Exp Clin Cancer Res 22 51-v68

[9] Aigner KR(2015)Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 26 v56-e28

[10] Selak E(2017)Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysis Clin Res Hepatol Gastroenterol 41 e26-2925